{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:24:58Z","timestamp":1769520298826,"version":"3.49.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period","award":["2014BAI09B10"],"award-info":[{"award-number":["2014BAI09B10"]}]},{"name":"the Health & Medical Collaborative Innovation Project of Guangzhou City, China","award":["201400000001"],"award-info":[{"award-number":["201400000001"]}]},{"name":"the Science and Technology Project of Guangzhou City, China","award":["14570006"],"award-info":[{"award-number":["14570006"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196730","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T17:48:13Z","timestamp":1525283293000},"page":"e0196730","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["The current status of clinical trials focusing on nasopharyngeal carcinoma: A comprehensive analysis of ClinicalTrials.gov database"],"prefix":"10.1371","volume":"13","author":[{"given":"Hao","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Long","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1137-9349","authenticated-orcid":true,"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.ejca.2010.04.004","article-title":"Nasopharyngeal carcinoma: the next challenges","volume":"46","author":"AR Razak","year":"2010","journal-title":"Eur J Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities","volume":"110","author":"X Sun","year":"2014","journal-title":"Radiother Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"15638","DOI":"10.1038\/srep15638","article-title":"Development and External Validation of Nomograms for Predicting Survival in Nasopharyngeal Carcinoma Patients after Definitive Radiotherapy","volume":"5","author":"L Yang","year":"2015","journal-title":"Sci Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ejca.2015.08.006","article-title":"Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up","volume":"51","author":"MX Zhang","year":"2015","journal-title":"Eur J Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2005.12.003","article-title":"Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution","volume":"65","author":"JL Yi","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","article-title":"Nasopharyngeal carcinoma","volume":"365","author":"WI Wei","year":"2005","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMe048225","article-title":"Clinical trial registration: a statement from the International Committee of Medical Journal Editors","volume":"351","author":"C De Angelis","year":"2004","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJMsa1409364","article-title":"Compliance with results reporting at ClinicalTrials.gov","volume":"372","author":"ML Anderson","year":"2015","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMoa032260","article-title":"Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma","volume":"350","author":"JC Lin","year":"2004","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","article-title":"The enigmatic epidemiology of nasopharyngeal carcinoma","volume":"15","author":"ET Chang","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/1097-0142(197909)44:3<1029::AID-CNCR2820440335>3.0.CO;2-5","article-title":"Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics","volume":"44","author":"K Shanmugaratnam","year":"1979","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1044579X02000858","article-title":"Epidemiology of nasopharyngeal carcinoma","volume":"12","author":"MC Yu","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.28.11.2398-2402.1990","article-title":"Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification","volume":"28","author":"YS Chang","year":"1990","journal-title":"J Clin Microbiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000150327","article-title":"Detection of Epstein-Barr virus genome in nasopharyngeal carcinoma by in situ DNA hybridization","volume":"36","author":"CL Chen","year":"1993","journal-title":"Intervirology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<231::AID-CNCR2>3.0.CO;2-P","article-title":"Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes","volume":"77","author":"ST Tsai","year":"1996","journal-title":"Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/jnci\/94.21.1614","article-title":"Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma","volume":"94","author":"AT Chan","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/cncr.11496","article-title":"Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type","volume":"98","author":"SF Leung","year":"2003","journal-title":"Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/annonc\/mdu117","article-title":"Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma","volume":"25","author":"SF Leung","year":"2014","journal-title":"Ann Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1200\/JCO.2006.07.7982","article-title":"Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma","volume":"24","author":"SF Leung","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2001.19.10.2607","article-title":"Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival","volume":"19","author":"JC Lin","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.ijrobp.2007.02.012","article-title":"Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy","volume":"68","author":"JC Lin","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ijrobp.2006.05.064","article-title":"Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma","volume":"66","author":"BB Ma","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"22000","DOI":"10.1038\/srep22000","article-title":"Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation Therapy","volume":"6","author":"H Peng","year":"2016","journal-title":"Sci Rep"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1002\/cncr.25932","article-title":"Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic\/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy","volume":"117","author":"X An","year":"2011","journal-title":"Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejca.2011.09.004","article-title":"To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area","volume":"48","author":"Y Jin","year":"2012","journal-title":"Eur J Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"16664","DOI":"10.1038\/srep16664","article-title":"Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy","volume":"5","author":"XJ Du","year":"2015","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.7150\/jca.15736","article-title":"Prognostic Value of Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma with Low Pre-treatment Epstein-Barr Virus DNA: a Propensity-matched Analysis","volume":"7","author":"H Peng","year":"2016","journal-title":"J Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2014.01.052","article-title":"Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid","volume":"89","author":"CW Twu","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0360-3016(92)90740-9","article-title":"Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976\u20131985: overall survival and patterns of failure","volume":"23","author":"AW Lee","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1259\/0007-1285-63-746-108","article-title":"Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failure","volume":"63","author":"JS Sham","year":"1990","journal-title":"Br J Radiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2423::AID-CNCR2>3.0.CO;2-N","article-title":"Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma","volume":"77","author":"PM Teo","year":"1996","journal-title":"Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0140-6736(16)31388-5","article-title":"Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial","volume":"388","author":"L Zhang","year":"2016","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T12:58:58Z","timestamp":1604235538000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196730"}},"subtitle":[],"editor":[{"given":"Joseph S","family":"Pagano","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196730","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]}}}